Valuation: Alembic Pharmaceuticals Limited

Market Cap 16TCr 172.59Cr 150.96Cr 139.24Cr 128.6Cr 244.02Cr 248.13Cr 1.66TCr 653.34Cr 8.11TCr 648.01Cr 633.91Cr 28TCr P/E 2026
19.3x
P/E 2027 * 22.1x
Enterprise Value 17TCr 179.34Cr 156.87Cr 144.69Cr 133.64Cr 253.57Cr 257.84Cr 1.73TCr 678.92Cr 8.43TCr 673.37Cr 658.72Cr 29TCr EV / Sales 2026
1.93x
EV / Sales 2027 * 2.12x
Free-Float
29.3%
Yield 2026
1.81%
Yield 2027 * 1.54%
1 day+2.51%
1 week+1.66%
Current month+1.78%
1 month+13.99%
3 months+15.63%
6 months+4.68%
Current year-1.03%
1 week 801.25
Extreme 801.25
842.8
1 month 735.55
Extreme 735.55
846
Current year 635.8
Extreme 635.8
847.95
1 year 635.8
Extreme 635.8
1,044.8
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 07/07/2025
Chief Operating Officer - 21/07/2025
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 50 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap.
28/25/28
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/25/24
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/25/21Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+2.51%+1.66%-14.25%+27.34% 172.59Cr
-2.33%-2.09%+49.88%+170.51% 1,06000Cr
-0.82%-2.30%+63.79%+62.00% 62TCr
-0.73%-4.98%+28.91%+82.99% 44TCr
+0.33%-1.17%+31.07%+27.09% 33TCr
-0.02%-2.85%+29.15%+45.24% 28TCr
-3.89%-11.22%+22.81%+27.30% 27TCr
+0.66%-1.42%-26.59%-37.71% 22TCr
-0.06%-2.88%+23.07%+62.33% 20TCr
-3.72%-1.10%+18.41%+70.56% 16TCr
Average -0.81%-2.75%+22.63%+53.76% 35.76TCr
Weighted average by Cap. -1.31%-2.95%+36.72%+83.88%

Financials

2026 2027 *
Net sales 7.43TCr 78Cr 68Cr 63Cr 58Cr 110.14Cr 111.99Cr 750.92Cr 294.89Cr 3.66TCr 292.48Cr 286.12Cr 13TCr 8.22TCr 86Cr 75Cr 69Cr 64Cr 121.79Cr 123.84Cr 830.38Cr 326.09Cr 4.05TCr 323.43Cr 316.39Cr 14TCr
Net income 666.34Cr 6.99Cr 6.11Cr 5.64Cr 5.21Cr 9.88Cr 10Cr 67Cr 26Cr 328.26Cr 26Cr 26Cr 1.13TCr 751.29Cr 7.88Cr 6.89Cr 6.36Cr 5.87Cr 11Cr 11Cr 76Cr 30Cr 370.11Cr 30Cr 29Cr 1.27TCr
Net Debt 644.35Cr 6.76Cr 5.91Cr 5.45Cr 5.03Cr 9.55Cr 9.71Cr 65Cr 26Cr 317.43Cr 25Cr 25Cr 1.09TCr 943.08Cr 9.89Cr 8.65Cr 7.98Cr 7.37Cr 14Cr 14Cr 95Cr 37Cr 464.59Cr 37Cr 36Cr 1.6TCr
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
16,571
Date Price Change Volume
10/26/10 ₹837.40 +2.51% 1,09,731
09/26/09 ₹816.90 +0.69% 62,063
08/26/08 ₹811.30 -2.18% 1,50,088
07/26/07 ₹829.35 -0.75% 81,550
06/26/06 ₹835.65 +1.45% 2,26,133
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
837.40INR
Average target price
918.20INR
Spread / Average Target
+9.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock